FDA Warns of Confusion Between Brintellix, Brilinta

Share this content:
FDA Warns of Confusion Between Brintellix, Brilinta
FDA Warns of Confusion Between Brintellix, Brilinta

FRIDAY, July 31, 2015 (HealthDay News) -- Confusion between the names of the antidepressant Brintellix (vortioxetine) and the antiplatelet Brilinta (ticagrelor) has led to the wrong medication being prescribed or dispensed, the U.S. Food and Drug Administration says.

While none of the reports indicate that a patient has used the wrong medication, reports of prescribing and dispensing errors are still being received by the FDA.

Physicians can reduce the risk of name confusion by including the generic name of the medication on prescriptions in addition to the brand name, along with the indication for their use.

In a safety announcement, the FDA urges "patients and health care professionals to report name confusion and medication errors involving Brintellix and Brilinta to the FDA MedWatch program."

More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease


More in Home

Dermatography Helps Lessen Appearance of Surgical Scars

Dermatography Helps Lessen Appearance of Surgical Scars

Pigments can restore more natural skin appearance that patients are happy with

Drug-Resistant Bacteria Live in America's Water Systems

Drug-Resistant Bacteria Live in America's Water Systems

Bacteria found in plumbing may sicken thousands each year

Deep Brain Stimulation May Improve TBI Symptoms

Deep Brain Stimulation May Improve TBI Symptoms

Deep brain stimulation appears to boost function and quality of life

is free, fast, and customized just for you!

Already a member?

Sign In Now »